{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:35Z","timestamp":1707524495770},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,14]]},"DOI":"10.7759\/cureus.22217","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T06:25:44Z","timestamp":1644906344000},"source":"Crossref","is-referenced-by-count":1,"title":["Coexistence of Trisomy 8 and 13 in a Newly Diagnosed Patient With Diffuse Large B Cell Non-Hodgkin Lymphoma and Acute Myeloid Leukemia Secondary to Primary Myelofibrosis"],"prefix":"10.7759","author":[{"given":"Horia","family":"Bumbea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola Maria","family":"Popov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian","family":"Tomuleasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilin","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Dobrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Manea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Zurac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Popp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ion","family":"Dumitru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Simoiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Mastalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li S","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018, 50:74-87. 10.1016\/j.pathol.2017.09.006","journal-title":"Pathology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000347159","article-title":"Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin's lymphoma: a case report and review of the literature","volume":"130","author":"Elli EM","year":"2013","unstructured":"Elli EM, Belotti A, Cecchetti C, Realini S, Fedele M, Parma M, Pogliani EM. Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin's lymphoma: a case report and review of the literature. Acta Haematol. 2013, 130:142-5. 10.1159\/000347159","journal-title":"Acta Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0353","article-title":"Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"18","author":"Vannucchi AM","year":"2009","unstructured":"Vannucchi AM, Masala G, Antonioli E, et al.. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev. 2009, 18:2068-73. 10.1158\/1055-9965.EPI-09-0353","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103061","article-title":"Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: clinical implications","volume":"12","author":"Brabrand M","year":"2020","unstructured":"Brabrand M, Frederiksen H. Risks of solid and lymphoid malignancies in patients with myeloproliferative neoplasms: clinical implications. Cancers (Basel). 2020, 12:10.3390\/cancers12103061","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-03-900951","article-title":"JAK inhibitors and risk of B-cell lymphomas","volume":"133","author":"Rumi E","year":"2019","unstructured":"Rumi E, Zibellini S. JAK inhibitors and risk of B-cell lymphomas. Blood. 2019, 133:2251-3. 10.1182\/blood-2019-03-900951","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.248","article-title":"Risk factors for second acute myeloid leukemia\/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma","volume":"30","author":"Lam CJ","year":"2016","unstructured":"Lam CJ, Curtis RE, Dores GM, et al.. Risk factors for second acute myeloid leukemia\/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. Leukemia. 2016, 30:1187-90. 10.1038\/leu.2015.248","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197912)44:6<2316::aid-cncr2820440647>3.0.co;2-6","article-title":"Acute myeloblastic leukemia developing in patients with mediastinal lymphoblastic lymphoma","volume":"44","author":"Kjeldsberg CR","year":"1979","unstructured":"Kjeldsberg CR, Nathwani BN, Rappaport H. Acute myeloblastic leukemia developing in patients with mediastinal lymphoblastic lymphoma. Cancer. 1979, 44:2316-23. 10.1002\/1097-0142(197912)44:6&lt;2316::aid-cncr2820440647&gt;3.0.co;2-6","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.06.001","article-title":"CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype","volume":"31","author":"Chang H","year":"2007","unstructured":"Chang H, Yeung J, Brandwein J, Yi QL. CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk Res. 2007, 31:157-62. 10.1016\/j.leukres.2006.06.001","journal-title":"Leuk Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0971-6866.96673","article-title":"Trisomy 8 in leukemia: a GCRI experience","volume":"18","author":"Bakshi SR","year":"2012","unstructured":"Bakshi SR, Brahmbhatt MM, Trivedi PJ, et al.. Trisomy 8 in leukemia: a GCRI experience. Indian J Hum Genet. 2012, 18:106-8. 10.4103\/0971-6866.96673","journal-title":"Indian J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4267\/2042\/44390","article-title":"+8 or trisomy 8","volume":"13","author":"Huret JL","year":"2009","unstructured":"Huret JL. +8 or trisomy 8. Atlas Genet Cytogenet Oncol Haematol. 2009, 13:75-7. 10.4267\/2042\/44390","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4267\/2042\/47494","article-title":"+13 or trisomy 13","volume":"8","author":"Lee RE","year":"2012","unstructured":"Lee RE, Dal CP. +13 or trisomy 13. Atlas Genet Cytogenet Oncol Haematol. 2012, 8:572-3. 10.4267\/2042\/47494","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.05.003","article-title":"De novo CD5+ diffuse large B-cell lymphoma: biology, mechanism, and treatment advances","volume":"20","author":"Xu Y","year":"2020","unstructured":"Xu Y, Sun W, Li F. De novo CD5+ diffuse large B-cell lymphoma: biology, mechanism, and treatment advances. Clin Lymphoma Myeloma Leuk. 2020, 20:e782-90. 10.1016\/j.clml.2020.05.003","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-2933-x","article-title":"Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia","volume":"96","author":"Ito S","year":"2017","unstructured":"Ito S, Fujiwara SI, Mashima K, et al.. Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Ann Hematol. 2017, 96:719-24. 10.1007\/s00277-017-2933-x","journal-title":"Ann Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2006.05.019","article-title":"Trisomy 8 as sole cytogenetic abnormality in a case of chronic lymphocytic leukemia","volume":"172","author":"Lau LC","year":"2007","unstructured":"Lau LC, Kee SK, Tien SL, Koh Mickey BC. Trisomy 8 as sole cytogenetic abnormality in a case of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2007, 172:66-9. 10.1016\/j.cancergencyto.2006.05.019","journal-title":"Cancer Genet Cytogenet"},{"key":"ref15","article-title":"The cytogenetics of hematologic neoplasms","author":"Meloni-Ehrig A","year":"2013","unstructured":"Meloni-Ehrig A. The cytogenetics of hematologic neoplasms. The Principles of Clinical Cytogenetics, Third Edition. Gersen SL, Keagle MB (ed): Springer Science+Business Media, New York; 2013. 309-70."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/10428199209053596","article-title":"Trisomy 13 in acute leukemia","volume":"7","author":"Baer MR","year":"1992","unstructured":"Baer MR, Bloomfield CD. Trisomy 13 in acute leukemia. Leuk Lymphoma. 1992, 7:1-6. 10.3109\/10428199209053596","journal-title":"Leuk Lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909145748","article-title":"Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia","volume":"35","author":"Zojer N","year":"1999","unstructured":"Zojer N, Meran JG, Vesely M, et al.. Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia. Leuk Lymphoma. 1999, 35:415-21. 10.3109\/10428199909145748","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons","volume":"28","author":"Tefferi A","year":"2014","unstructured":"Tefferi A, Lasho TL, Finke CM, et al.. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia. 2014, 28:1472-7. 10.1038\/leu.2014.3","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.58.228","article-title":"18F-FDG-PET\/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis","volume":"58","author":"Kumagai T","year":"2017","unstructured":"Kumagai T, Satoh Y, Koshiishi M, et al.. 18F-FDG-PET\/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis. Rinsho Ketsueki. 2017, 58:228-32. 10.11406\/rinketsu.58.228","journal-title":"Rinsho Ketsueki"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7426739","article-title":"Chronic lymphocytic leukemia and myelofibrosis","volume":"2018","author":"Darawshy F","year":"2018","unstructured":"Darawshy F, Ben-Yehuda A, Atlan K, Rund D. Chronic lymphocytic leukemia and myelofibrosis. Case Rep Hematol. 2018, 2018:7426739. 10.1155\/2018\/7426739","journal-title":"Case Rep Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86615-coexistence-of-trisomy-8-and-13-in-a-newly-diagnosed-patient-with-diffuse-large-b-cell-non-hodgkin-lymphoma-and-acute-myeloid-leukemia-secondary-to-primary-myelofibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:14Z","timestamp":1707507434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86615-coexistence-of-trisomy-8-and-13-in-a-newly-diagnosed-patient-with-diffuse-large-b-cell-non-hodgkin-lymphoma-and-acute-myeloid-leukemia-secondary-to-primary-myelofibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22217","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}